Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Other financing activities (2017 - 2025)

Selectis Health's Other financing activities history spans 10 years, with the latest figure at $2000.0 for Q3 2025.

  • For Q3 2025, Other financing activities fell 87.95% year-over-year to $2000.0; the TTM value through Sep 2025 reached $3050.0, down 93.69%, while the annual FY2024 figure was $34150.0, 59.86% up from the prior year.
  • Other financing activities for Q3 2025 was $2000.0 at Selectis Health, down from $2500.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $37489.0 in Q4 2022 and bottomed at -$29019.0 in Q4 2021.
  • The 5-year median for Other financing activities is $5499.0 (2022), against an average of $5431.5.
  • The largest YoY upside for Other financing activities was 500.0% in 2021 against a maximum downside of 1913.69% in 2021.
  • A 5-year view of Other financing activities shows it stood at -$29019.0 in 2021, then skyrocketed by 229.19% to $37489.0 in 2022, then tumbled by 75.03% to $9362.0 in 2023, then tumbled by 151.81% to -$4850.0 in 2024, then surged by 141.24% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Other financing activities are $2000.0 (Q3 2025), $2500.0 (Q2 2025), and $3400.0 (Q1 2025).